&nbsp;

PhysicalHealthforGynecologicalCancerSurvivors.pdf

Jul 2024

Document

Physical-Health-for-Gynecological-Cancer_FR.pdf

Jul 2024

Politique de financement des essais cliniques pour les thérapies par lymphocytes T à récepteur antigénique chimérique (CAR-T)

Regimen

PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Adjuvant

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

PEMB

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Treatment for Completely Resectable Stage III or IV Melanoma

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

FRUQ

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

fruquintinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

PEME+CEMI(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

cemiplimab (Compassionate)

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

PEME+OSIM(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

osimertinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2024

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Document

Postcard.zip

New

Nov 2024

Document

Poster.zip

New

Nov 2024

Regimen

POMP

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

prednisone

ODB - General Benefit

methotrexate - oral tablets

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

New Drug Funding Program

Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia

Drugs Used: